Striverdi Respimat
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Striverdi Respimat, covering 2011-11-22 to 2024-12-27. Get the full timeline:
Most recent: FDA Approved: STRIVERDI RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)